Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Buy Moody’s Corporation (NYSE:MCO)?

Is Moody’s Corporation (NYSE:MCO) a buy, sell, or hold? The best stock pickers are getting more optimistic. The number of bullish hedge fund bets advanced by 3 in recent months.

In the 21st century investor’s toolkit, there are plenty of methods shareholders can use to track publicly traded companies. A duo of the best are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the top investment managers can outperform the broader indices by a very impressive amount (see just how much).

Equally as important, optimistic insider trading sentiment is another way to parse down the marketplace. There are many incentives for a bullish insider to sell shares of his or her company, but just one, very simple reason why they would behave bullishly. Several academic studies have demonstrated the useful potential of this method if “monkeys” know where to look (learn more here).

Keeping this in mind, we’re going to take a glance at the key action surrounding Moody’s Corporation (NYSE:MCO).

How are hedge funds trading Moody’s Corporation (NYSE:MCO)?

In preparation for this year, a total of 27 of the hedge funds we track were bullish in this stock, a change of 13% from the third quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists an “upper tier” of notable hedge fund managers who were upping their stakes meaningfully.

When looking at the hedgies we track, Berkshire Hathaway, managed by Warren Buffett, holds the largest position in Moody’s Corporation (NYSE:MCO). Berkshire Hathaway has a $1.43 billion position in the stock, comprising 1.9% of its 13F portfolio. Coming in second is Jeffrey Ubben of ValueAct Capital, with a $757 million position; 9.5% of its 13F portfolio is allocated to the company. Some other hedgies that hold long positions include Chris Hohn’s Childrens Investment Fund, Charles Akre’s Akre Capital Management and Tiger Global Management LLC.

With a general bullishness amongst the heavyweights, key money managers have been driving this bullishness. Childrens Investment Fund, managed by Chris Hohn, established the largest position in Moody’s Corporation (NYSE:MCO). Childrens Investment Fund had 135 million invested in the company at the end of the quarter. Lou Simpson’s SQ Advisors also made a $59 million investment in the stock during the quarter. The following funds were also among the new MCO investors: Eric Mindich’s Eton Park Capital, David Stemerman’s Conatus Capital Management, and Christian Leone’s Luxor Capital Group.

Insider trading activity in Moody’s Corporation (NYSE:MCO)

Insider trading activity, especially when it’s bullish, is particularly usable when the primary stock in question has seen transactions within the past six months. Over the latest six-month time period, Moody’s Corporation (NYSE:MCO) has experienced 2 unique insiders purchasing, and 2 insider sales (see the details of insider trades here).

With the results exhibited by the aforementioned time-tested strategies, everyday investors should always monitor hedge fund and insider trading sentiment, and Moody’s Corporation (NYSE:MCO) applies perfectly to this mantra.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!